\-\ Texto\\:\\ \ \(0\)\
\-\ initial\\ vital\\ signs\\ demonstrated\\ significant\\ hypertension\\ \\(150\\/90\\)\ \(0\)\
\-\ lowering\\ the\\ blood\\ pressure\\ is\\ usually\\ sufficient\\ to\\ reverse\\ the\\ symptoms\\ and\\ findings\\.\\ \\ however\\,\\ diuretics\\ and\\ ace\\ inhibitors\\ are\\ contraindicated\\ in\\ pregnancy\\.\\ ht\\ is\\ treated\\ with\\ beta\\-blockers\\,\\ methyldopa\\,\\ and\\ hydralazine\\.\\ magnesium\\ sulfate\\ is\\ used\\ to\\ control\\ seizures\\.\ \(0\)\
\-\ bilateral\\ occipital\\ lesions\\ of\\ abnormal\\ decreased\\ attenuation\\ \\-\\ mostly\\ in\\ the\\ posterior\\ white\\ matter\\,\\ with\\ some\\ areas\\ also\\ involving\\ into\\ the\\ cortical\\ gray\\ matter\\.\ \(0\)\
\-\ reversible\\ posterior\\ leukoencephalopathy\\ from\\ eclampsia\\ \\(toxemia\\ of\\ pregnancy\\)\ \(0\)\
\-\ \\<li\\>top\\ of\\ the\\ basilar\\ syndrome\ \(0\)\
\-\ \\<li\\>superior\\ sagittal\\ sinus\\ thrombosis\ \(0\)\
\-\ \\<li\\>eclampsia\ \(0\)\
\-\ \\<li\\>cyclosporin\\ toxicity\ \(0\)\
\-\ \\<li\\>pres\\ \\(posterior\\ reversible\\ encephalopathy\\ syndrome\\)\ \(0\)\
\-\ this\\ 20\\ year\\ old\\ pregnant\\ woman\\ presented\\ to\\ the\\ emergency\\ room\\ with\\ decreased\\ vision\\ following\\ a\\ seizure\\.\ \(0\)\
\-\ companion\\ cases\\:\ \(4\)\
\-\ http\\:\\/\\/rad\\.usuhs\\.edu\\/medpix\\/parent\\.php3\\?mode\\=tfcase\\_thumbnails\\&case\\_prog\\=\\/medpix\\/cow\\_image\\.php\\&pt\\_id\\=12932\ \(0\)\
\-\ http\\:\\/\\/www\\.vh\\.org\\/providers\\/clinref\\/fphandbook\\/chapter14\\/12\\-14\\.html\ \(0\)\
\-\ http\\:\\/\\/www\\.acponline\\.org\\/journals\\/ebm\\/janfeb96\\/magsul1\\.htm\ \(1\)\
\-\ http\\:\\/\\/bmj\\.com\\/cgi\\/content\\/full\\/318\\/7186\\/751\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ li\\:\\ 0\\.14051970823843157\ \(0\)\
\-\ \\<\\:\\ 0\\.10179214591054908\ \(0\)\
\-\ eclampsia\\:\\ 0\\.09171881559069886\ \(0\)\
\-\ \\>\\:\\ 0\\.08762862699594334\ \(0\)\
\-\ http\\:\\ 0\\.07989601476494508\ \(0\)\
\-\ reversible\\:\\ 0\\.07067254284701459\ \(0\)\
\-\ 150\\/90\\:\\ 0\\.054416780394854924\ \(0\)\
\-\ hydralazine\\:\\ 0\\.054416780394854924\ \(0\)\
\-\ toxemia\\:\\ 0\\.054416780394854924\ \(0\)\
\-\ case\\_prog\\=\\/medpix\\/cow\\_image\\.php\\:\\ 0\\.054416780394854924\ \(0\)\
\-\ pt\\_id\\=12932\\:\\ 0\\.054416780394854924\ \(0\)\
\-\ \\/\\/www\\.vh\\.org\\/providers\\/clinref\\/fphandbook\\/chapter14\\/12\\-14\\.html\\:\\ 0\\.054416780394854924\ \(0\)\
\-\ \\/\\/www\\.acponline\\.org\\/journals\\/ebm\\/janfeb96\\/magsul1\\.htm\\:\\ 0\\.054416780394854924\ \(0\)\
\-\ \\/\\/bmj\\.com\\/cgi\\/content\\/full\\/318\\/7186\\/751\\:\\ 0\\.054416780394854924\ \(0\)\
\-\ methyldopa\\:\\ 0\\.05013809409510218\ \(0\)\
\-\ cyclosporin\\:\\ 0\\.04763522305739746\ \(0\)\
\-\ beta\\-blockers\\:\\ 0\\.04585940779534943\ \(0\)\
\-\ pregnancy\\:\\ 0\\.04535623293165232\ \(0\)\
\-\ lowering\\:\\ 0\\.044481978466249364\ \(0\)\
\-\ magnesium\\:\\ 0\\.044481978466249364\ \(0\)\
\-\ mode\\=tfcase\\_thumbnails\\:\\ 0\\.044481978466249364\ \(0\)\
\-\ sulfate\\:\\ 0\\.043356536757644705\ \(0\)\
\-\ diuretics\\:\\ 0\\.041580721495596676\ \(0\)\
\-\ matter\\:\\ 0\\.041536789758034535\ \(0\)\
\-\ \\/\\/rad\\.usuhs\\.edu\\/medpix\\/parent\\.php3\\:\\ 0\\.04085366571993999\ \(0\)\
\-\ inhibitors\\:\\ 0\\.03907785045789196\ \(0\)\
\-\ reverse\\:\\ 0\\.03812630305155086\ \(0\)\
\-\ pres\\:\\ 0\\.0377004211287919\ \(0\)\
\-\ contraindicated\\:\\ 0\\.03730203519584393\ \(0\)\
\-\ \\&\\:\\ 0\\.037054171507918905\ \(0\)\
\-\ ace\\:\\ 0\\.03692780913524865\ \(0\)\
\-\ toxicity\\:\\ 0\\.03692780913524865\ \(0\)\
\-\ leukoencephalopathy\\:\\ 0\\.03657497942018725\ \(0\)\
\-\ posterior\\:\\ 0\\.03647478793893423\ \(0\)\
\-\ ht\\:\\ 0\\.03592460586674387\ \(0\)\
\-\ \\:\\:\\ 0\\.03488502518489707\ \(0\)\
\-\ sufficient\\:\\ 0\\.032833400385802576\ \(0\)\
\-\ companion\\:\\ 0\\.03196254484098835\ \(0\)\
\-\ decreased\\:\\ 0\\.0313673629965995\ \(0\)\
\-\ encephalopathy\\:\\ 0\\.031057585123754547\ \(0\)\
\-\ pregnant\\:\\ 0\\.031057585123754547\ \(0\)\
\-\ mostly\\:\\ 0\\.03078319152763829\ \(0\)\
\-\ syndrome\\:\\ 0\\.030171686132526437\ \(0\)\
\-\ top\\:\\ 0\\.02828032048993357\ \(0\)\
\-\ basilar\\:\\ 0\\.0276838585412356\ \(0\)\
\-\ gray\\:\\ 0\\.025807342195906555\ \(0\)\
\-\ vital\\:\\ 0\\.025235374106507145\ \(0\)\
\-\ occipital\\:\\ 0\\.024612374609038253\ \(0\)\
\-\ vision\\:\\ 0\\.024370271441425406\ \(0\)\
\-\ control\\:\\ 0\\.024046527766286255\ \(0\)\
\-\ seizure\\:\\ 0\\.02332448037995598\ \(0\)\
\-\ seizures\\:\\ 0\\.02267811646582616\ \(0\)\
\-\ room\\:\\ 0\\.02267811646582616\ \(0\)\
\-\ thrombosis\\:\\ 0\\.02264212313057435\ \(0\)\
\-\ attenuation\\:\\ 0\\.02120753747176567\ \(0\)\
\-\ sagittal\\:\\ 0\\.021039176867323327\ \(0\)\
\-\ hypertension\\:\\ 0\\.02079494476728511\ \(0\)\
\-\ pressure\\:\\ 0\\.020715635245816908\ \(0\)\
\-\ \\?\\:\\ 0\\.020585675929780903\ \(0\)\
\-\ used\\:\\ 0\\.02023570467251828\ \(0\)\
\-\ emergency\\:\\ 0\\.01997400369123627\ \(0\)\
\-\ sinus\\:\\ 0\\.019291104750879244\ \(0\)\
\-\ cortical\\:\\ 0\\.019228857102319825\ \(0\)\
\-\ 20\\:\\ 0\\.018966143433068\ \(0\)\
\-\ signs\\:\\ 0\\.01856404897522256\ \(0\)\
\-\ involving\\:\\ 0\\.018508686814835144\ \(0\)\
\-\ areas\\:\\ 0\\.01774905661263004\ \(0\)\
\-\ cases\\:\\ 0\\.017572906567784766\ \(0\)\
\-\ white\\:\\ 0\\.017494470448839616\ \(0\)\
\-\ initial\\:\\ 0\\.017478902119008072\ \(0\)\
\-\ superior\\:\\ 0\\.016844096895396243\ \(0\)\
\-\ usually\\:\\ 0\\.016018075641152832\ \(0\)\
\-\ some\\:\\ 0\\.016018075641152832\ \(0\)\
\-\ treated\\:\\ 0\\.015789202691875674\ \(0\)\
\-\ demonstrated\\:\\ 0\\.015477901126277576\ \(0\)\
\-\ abnormal\\:\\ 0\\.015043779261203155\ \(0\)\
\-\ following\\:\\ 0\\.014970850351241656\ \(0\)\
\-\ however\\:\\ 0\\.014687457133315249\ \(0\)\
\-\ blood\\:\\ 0\\.014397599213020366\ \(0\)\
\-\ presented\\:\\ 0\\.01437875083347166\ \(0\)\
\-\ significant\\:\\ 0\\.014184241673174218\ \(0\)\
\-\ lesions\\:\\ 0\\.014120743866320664\ \(0\)\
\-\ \\(\\:\\ 0\\.013377069004515935\ \(0\)\
\-\ \\)\\:\\ 0\\.013213660965061205\ \(0\)\
\-\ symptoms\\:\\ 0\\.013146033808013203\ \(0\)\
\-\ bilateral\\:\\ 0\\.01280134400811385\ \(0\)\
\-\ into\\:\\ 0\\.012551397333084609\ \(0\)\
\-\ woman\\:\\ 0\\.012184586095610532\ \(0\)\
\-\ \\-\\:\\ 0\\.01130696579449607\ \(0\)\
\-\ findings\\:\\ 0\\.011227388492530615\ \(0\)\
\-\ is\\:\\ 0\\.010412792192309733\ \(0\)\
\-\ also\\:\\ 0\\.010398886380679945\ \(0\)\
\-\ to\\:\\ 0\\.007908668674870115\ \(0\)\
\-\ from\\:\\ 0\\.007817504402186495\ \(0\)\
\-\ are\\:\\ 0\\.007190579460059269\ \(0\)\
\-\ \\,\\:\\ 0\\.006684199148574997\ \(0\)\
\-\ this\\:\\ 0\\.005932945761198352\ \(0\)\
\-\ year\\:\\ 0\\.005901884378227869\ \(0\)\
\-\ old\\:\\ 0\\.005400830844828732\ \(0\)\
\-\ in\\:\\ 0\\.005202434940003147\ \(0\)\
\-\ the\\:\\ 0\\.005120343877912066\ \(0\)\
\-\ and\\:\\ 0\\.0033335001061521935\ \(0\)\
\-\ a\\:\\ 0\\.0024481469248061804\ \(0\)\
\-\ with\\:\\ 0\\.0021667440016646246\ \(0\)\
\-\ of\\:\\ 0\\.0021574777925553413\ \(0\)\
\-\ \\.\\:\\ 0\\.0013147976332350472\ \(0\)\
